Pancreatic Cancer Research

ResearcherThe First Hospital of ChangshaActive in the last 2 years

Qinghua Yin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0007-6721-5937; OpenAlex author ID A5102632663. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 3

  1. [Retracted] SIRT6 promotes ferroptosis and attenuates glycolysis in pancreatic cancer through regulation of the NF‑κB pathway. Co-author DOI 10.3892/etm.2024.12751↗
  2. SIRT6 promotes ferroptosis and attenuates glycolysis in pancreatic cancer through regulation of the NF-κB pathway. Co-author DOI 10.3892/etm.2022.11430↗
  3. miR-373 Suppresses Cell Proliferation and Apoptosis via Regulation of SIRT1/PGC-1α/NRF2 Axis in Pancreatic Cancer. Co-author DOI 10.22074/cellj.2021.7038↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shuangxi Gong · 2 shared papers, 2022–2025 · strength 0.46
  2. Zhen Luo · 2 shared papers, 2022–2025 · strength 0.46
  3. Jian Li · 2 shared papers, 2022–2025 · strength 0.46
  4. Z Hi Yuan Li · 1 shared paper, 2021 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.